Beyond Cancer Secures Approval From Israeli Ministry Of Health For Phase 1b Trial Combining Low Volume Ultra-High Concentration Nitric Oxide With Anti-PD-1 Therapy In Solid Tumor Patients
Beyond Cancer Secures Approval From Israeli Ministry Of Health For Phase 1b Trial Combining Low Volume Ultra-High Concentration Nitric Oxide With Anti-PD-1 Therapy In Solid Tumor Patients
癌症公司獲得以色列衛生部批准，進行第10億階段試驗，將低成交量超高濃度一氧化氮與抗PD-1療法結合治療實體腫瘤患者。
Beyond Cancer Secures Approval From Israeli Ministry Of Health For Phase 1b Trial Combining Low Volume Ultra-High Concentration Nitric Oxide With Anti-PD-1 Therapy In Solid Tumor Patients
癌症公司獲得以色列衛生部批准，進行第10億階段試驗，將低成交量超高濃度一氧化氮與抗PD-1療法結合治療實體腫瘤患者。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間